MDB Capital Collaborates with Mayo Clinic to Advance Anti-Senescence Platform
09 July 2024 - 6:16AM
MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”),
a public venture platform focused on launching category-leading
deep technology companies, today announced a collaboration through
a patent and know-how agreement with Mayo Clinic to develop a
small molecule anti-senescence platform. This collaboration aims to
advance research in longevity and age-related disease prevention.
Senescent cells, which are dysfunctional cells that have
permanently stopped dividing, have been implicated in the aging
process and the development of chronic low-grade inflammation. This
chronic inflammation has been linked to a variety of age-related
diseases, including multiple fibrotic conditions that have limited
treatment options and poor prognoses.
Studies conducted at Mayo Clinic have shown the potential of the
licensed molecule to target and eliminate senescent cells with a
significant therapeutic window, reversing fibrosis across multiple
conditions. The global longevity and anti-senescence therapy market
is projected to reach nearly $45 billion by 2030.
"We're thrilled to collaborate with Mayo Clinic to harness
clinical and scientific expertise to develop therapeutics that
could meaningfully improve patient lives across various
conditions,” said Christopher Marlett, CEO and Co-Founder of
MDB.
"Our team is deeply invested in addressing the underlying
drivers of aging and fibrotic conditions, which is why we are so
excited about this new collaborative effort,” said Dr. Andrew J.
Haak, PhD, Assistant Professor and Researcher at Mayo Clinic.
Mayo Clinic has a financial interest in the technology
referenced in this press release. Mayo Clinic will use any revenue
it receives to support its not-for-profit mission in patient care,
education and research.
About MDB Capital Holdings, LLC
Founded in 1997, MDB Capital focuses on launching “Big
Ideas” into valuable public companies with a better approach to
public venture capital. This approach involves community-driven
financings of pre-revenue, early-stage deep technology companies
through early public offerings, primarily listed on NASDAQ, as well
as post-IPO offerings for already public companies that fit MDB’s
overall criteria for investment.
MDB Capital is the brand under which MDB Capital Holdings, LLC
(NASDAQ: MDBH) and its subsidiaries operate and provide services,
which includes a self-clearing broker-dealer and trading platform
and an integrated, intellectual property (IP) strategy consulting
and law firm.
MDB Capital (a dba of Public Ventures, LLC) is a registered
broker-dealer, Member FINRA/SIPC.
For more information, please visit www.mdb.com.
Forward-Looking Statements
This press release contains "forward-looking statements." These
forward-looking statements are made as of the date they were first
issued and were based on current expectations, estimates, forecasts
and projections as well as the beliefs and assumptions of
management. Words such as "expect," "anticipate," "should,"
"believe," "hope," "target," "project," "goals," "estimate,"
"potential," "predict," "may," "will," "might," "could," "intend,"
"shall" and variations of these terms or the negative of these
terms and similar expressions are intended to identify these
forward-looking statements.
Forward-looking statements are subject to a number of risks and
uncertainties, many of which involve factors or circumstances that
are beyond MDB's control. MDB's actual results could differ
materially from those stated or implied in forward-looking
statements due to a number of factors, including but not limited
to, risks detailed in documents that may be filed by MDB from time
to time with the SEC. The forward-looking statements included in
this press release represent MDB's views as of the date of this
press release. MDB anticipates that subsequent events and
developments will cause its views to change. MDB undertakes no
intention or obligation to update or revise any forward-looking
statements, whether as a result of new information, future events
or otherwise. These forward-looking statements should not be relied
upon as representing MDB's views as of any date subsequent to the
date of this press release.
Investor Relations Contact:IR@mdb.com
Media Contact:press@mdb.com
SOURCE: MDB Capital Holdings, LLC
MDB Capital (NASDAQ:MDBH)
Historical Stock Chart
From Aug 2024 to Sep 2024
MDB Capital (NASDAQ:MDBH)
Historical Stock Chart
From Sep 2023 to Sep 2024